Loading…

Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion

Head and Neck Mucosal Melanoma (HNMM) is an uncommon malignancy that arises in decreasing order in the nasal cavity, the paranasal sinuses, and the oral cavity. Although radical surgery followed by eventual radiotherapy is acknowledged as the mainstay treatment, patients with advanced stages or mult...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in surgery 2021-01, Vol.7, p.616174-616174
Main Authors: Pincet, Laurence, Lambercy, Karma, Pasche, Philippe, Broome, Martin, Latifyan, Sofiya, Reinhard, Antoine
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3
cites cdi_FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3
container_end_page 616174
container_issue
container_start_page 616174
container_title Frontiers in surgery
container_volume 7
creator Pincet, Laurence
Lambercy, Karma
Pasche, Philippe
Broome, Martin
Latifyan, Sofiya
Reinhard, Antoine
description Head and Neck Mucosal Melanoma (HNMM) is an uncommon malignancy that arises in decreasing order in the nasal cavity, the paranasal sinuses, and the oral cavity. Although radical surgery followed by eventual radiotherapy is acknowledged as the mainstay treatment, patients with advanced stages or multi-focal tumors benefit from new systemic therapies. We wish to share our experience with these treatments and review the current literature. We present a case review of every patient treated in our center for an HNMM over the past 10 years, including every patient treated in our center for an HNMM over the past 10 years. We analyzed clinical characteristics, treatment modalities, and outcomes. We included eight patients aged from 62 to 85 years old. We found six MM in the nasal cavity, one in the sphenoidal sinus, and one in the piriform sinus. Six patients underwent endoscopic surgery with negative margins, six underwent radiotherapy with variable modalities. Immunotherapy or targeted therapy was given in cases extensive tumors without the possibility of a surgical treatment or in two patient as an adjuvant treatment after R0 surgery. The three-year overall survival was 50%, and three patients (37.5%) are in remission. HNMM is associated with poor oncologic outcomes regarding the concerned patients of our review, as reported in the literature. New treatments such as immunotherapies or targeted therapies have not significantly changed the prognosis, but they may offer new interesting perspectives. Our small series of cases seems to confirm that surgical resection with negative margins improves overall survival.
doi_str_mv 10.3389/fsurg.2020.616174
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8bfeac46a67040f6a2251dfaea45fe29</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_8bfeac46a67040f6a2251dfaea45fe29</doaj_id><sourcerecordid>2489598480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhq2qqKCUH9BL5WMvSf29dg-VUNQWJCgCUak3y-sdB9PNOrV3U_HvMQlFcPLYM-8znnkR-kDJgnNtPocy5dWCEUYWiiraiDfoiDGj5rqRv9--iA_RcSl3hBDKBVVMvEOHnEstpdBH6Opi8qm4Hl9A74a0djgFPN4CPgXXYTd0-Cf4P1_wCb6GMaeyAT_GLdTbNsK_XcFyyhmGEV9u4hDT8B4dBNcXOH46Z-jX9283y9P5-eWPs-XJ-dwLJcd5aCgY1QbhQiMCAce9F4F5YlRoCA9c-9Z0mhFNeBV4pgmYTgbJdWCUtHyGzvbcLrk7u8lx7fK9TS7a3UPKK-vyGH0PVrcBXG3rVEMECcoxJmkXHDghAzBTWV_3rM3UrqHzdZzs-lfQ15kh3tpV2tpGN9xwXQGfngA5_Z2gjHYdi4e-7hTSVCwT2kijRR1mhui-1Nd1lgzhuQ0l9tFZu3PWPjpr985WzceX_3tW_PeRPwD6dqDE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489598480</pqid></control><display><type>article</type><title>Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion</title><source>Open Access: PubMed Central</source><creator>Pincet, Laurence ; Lambercy, Karma ; Pasche, Philippe ; Broome, Martin ; Latifyan, Sofiya ; Reinhard, Antoine</creator><creatorcontrib>Pincet, Laurence ; Lambercy, Karma ; Pasche, Philippe ; Broome, Martin ; Latifyan, Sofiya ; Reinhard, Antoine</creatorcontrib><description>Head and Neck Mucosal Melanoma (HNMM) is an uncommon malignancy that arises in decreasing order in the nasal cavity, the paranasal sinuses, and the oral cavity. Although radical surgery followed by eventual radiotherapy is acknowledged as the mainstay treatment, patients with advanced stages or multi-focal tumors benefit from new systemic therapies. We wish to share our experience with these treatments and review the current literature. We present a case review of every patient treated in our center for an HNMM over the past 10 years, including every patient treated in our center for an HNMM over the past 10 years. We analyzed clinical characteristics, treatment modalities, and outcomes. We included eight patients aged from 62 to 85 years old. We found six MM in the nasal cavity, one in the sphenoidal sinus, and one in the piriform sinus. Six patients underwent endoscopic surgery with negative margins, six underwent radiotherapy with variable modalities. Immunotherapy or targeted therapy was given in cases extensive tumors without the possibility of a surgical treatment or in two patient as an adjuvant treatment after R0 surgery. The three-year overall survival was 50%, and three patients (37.5%) are in remission. HNMM is associated with poor oncologic outcomes regarding the concerned patients of our review, as reported in the literature. New treatments such as immunotherapies or targeted therapies have not significantly changed the prognosis, but they may offer new interesting perspectives. Our small series of cases seems to confirm that surgical resection with negative margins improves overall survival.</description><identifier>ISSN: 2296-875X</identifier><identifier>EISSN: 2296-875X</identifier><identifier>DOI: 10.3389/fsurg.2020.616174</identifier><identifier>PMID: 33585548</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>adjuvant radiation therapy ; endoscopic surgical procedure ; head and neck neoplasm ; immunotherapy ; late diagnosis ; melanoma ; Surgery</subject><ispartof>Frontiers in surgery, 2021-01, Vol.7, p.616174-616174</ispartof><rights>Copyright © 2021 Pincet, Lambercy, Pasche, Broome, Latifyan and Reinhard.</rights><rights>Copyright © 2021 Pincet, Lambercy, Pasche, Broome, Latifyan and Reinhard. 2021 Pincet, Lambercy, Pasche, Broome, Latifyan and Reinhard</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3</citedby><cites>FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873938/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873938/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33585548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pincet, Laurence</creatorcontrib><creatorcontrib>Lambercy, Karma</creatorcontrib><creatorcontrib>Pasche, Philippe</creatorcontrib><creatorcontrib>Broome, Martin</creatorcontrib><creatorcontrib>Latifyan, Sofiya</creatorcontrib><creatorcontrib>Reinhard, Antoine</creatorcontrib><title>Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion</title><title>Frontiers in surgery</title><addtitle>Front Surg</addtitle><description>Head and Neck Mucosal Melanoma (HNMM) is an uncommon malignancy that arises in decreasing order in the nasal cavity, the paranasal sinuses, and the oral cavity. Although radical surgery followed by eventual radiotherapy is acknowledged as the mainstay treatment, patients with advanced stages or multi-focal tumors benefit from new systemic therapies. We wish to share our experience with these treatments and review the current literature. We present a case review of every patient treated in our center for an HNMM over the past 10 years, including every patient treated in our center for an HNMM over the past 10 years. We analyzed clinical characteristics, treatment modalities, and outcomes. We included eight patients aged from 62 to 85 years old. We found six MM in the nasal cavity, one in the sphenoidal sinus, and one in the piriform sinus. Six patients underwent endoscopic surgery with negative margins, six underwent radiotherapy with variable modalities. Immunotherapy or targeted therapy was given in cases extensive tumors without the possibility of a surgical treatment or in two patient as an adjuvant treatment after R0 surgery. The three-year overall survival was 50%, and three patients (37.5%) are in remission. HNMM is associated with poor oncologic outcomes regarding the concerned patients of our review, as reported in the literature. New treatments such as immunotherapies or targeted therapies have not significantly changed the prognosis, but they may offer new interesting perspectives. Our small series of cases seems to confirm that surgical resection with negative margins improves overall survival.</description><subject>adjuvant radiation therapy</subject><subject>endoscopic surgical procedure</subject><subject>head and neck neoplasm</subject><subject>immunotherapy</subject><subject>late diagnosis</subject><subject>melanoma</subject><subject>Surgery</subject><issn>2296-875X</issn><issn>2296-875X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1PGzEQhq2qqKCUH9BL5WMvSf29dg-VUNQWJCgCUak3y-sdB9PNOrV3U_HvMQlFcPLYM-8znnkR-kDJgnNtPocy5dWCEUYWiiraiDfoiDGj5rqRv9--iA_RcSl3hBDKBVVMvEOHnEstpdBH6Opi8qm4Hl9A74a0djgFPN4CPgXXYTd0-Cf4P1_wCb6GMaeyAT_GLdTbNsK_XcFyyhmGEV9u4hDT8B4dBNcXOH46Z-jX9283y9P5-eWPs-XJ-dwLJcd5aCgY1QbhQiMCAce9F4F5YlRoCA9c-9Z0mhFNeBV4pgmYTgbJdWCUtHyGzvbcLrk7u8lx7fK9TS7a3UPKK-vyGH0PVrcBXG3rVEMECcoxJmkXHDghAzBTWV_3rM3UrqHzdZzs-lfQ15kh3tpV2tpGN9xwXQGfngA5_Z2gjHYdi4e-7hTSVCwT2kijRR1mhui-1Nd1lgzhuQ0l9tFZu3PWPjpr985WzceX_3tW_PeRPwD6dqDE</recordid><startdate>20210120</startdate><enddate>20210120</enddate><creator>Pincet, Laurence</creator><creator>Lambercy, Karma</creator><creator>Pasche, Philippe</creator><creator>Broome, Martin</creator><creator>Latifyan, Sofiya</creator><creator>Reinhard, Antoine</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210120</creationdate><title>Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion</title><author>Pincet, Laurence ; Lambercy, Karma ; Pasche, Philippe ; Broome, Martin ; Latifyan, Sofiya ; Reinhard, Antoine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>adjuvant radiation therapy</topic><topic>endoscopic surgical procedure</topic><topic>head and neck neoplasm</topic><topic>immunotherapy</topic><topic>late diagnosis</topic><topic>melanoma</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pincet, Laurence</creatorcontrib><creatorcontrib>Lambercy, Karma</creatorcontrib><creatorcontrib>Pasche, Philippe</creatorcontrib><creatorcontrib>Broome, Martin</creatorcontrib><creatorcontrib>Latifyan, Sofiya</creatorcontrib><creatorcontrib>Reinhard, Antoine</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Frontiers in surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pincet, Laurence</au><au>Lambercy, Karma</au><au>Pasche, Philippe</au><au>Broome, Martin</au><au>Latifyan, Sofiya</au><au>Reinhard, Antoine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion</atitle><jtitle>Frontiers in surgery</jtitle><addtitle>Front Surg</addtitle><date>2021-01-20</date><risdate>2021</risdate><volume>7</volume><spage>616174</spage><epage>616174</epage><pages>616174-616174</pages><issn>2296-875X</issn><eissn>2296-875X</eissn><abstract>Head and Neck Mucosal Melanoma (HNMM) is an uncommon malignancy that arises in decreasing order in the nasal cavity, the paranasal sinuses, and the oral cavity. Although radical surgery followed by eventual radiotherapy is acknowledged as the mainstay treatment, patients with advanced stages or multi-focal tumors benefit from new systemic therapies. We wish to share our experience with these treatments and review the current literature. We present a case review of every patient treated in our center for an HNMM over the past 10 years, including every patient treated in our center for an HNMM over the past 10 years. We analyzed clinical characteristics, treatment modalities, and outcomes. We included eight patients aged from 62 to 85 years old. We found six MM in the nasal cavity, one in the sphenoidal sinus, and one in the piriform sinus. Six patients underwent endoscopic surgery with negative margins, six underwent radiotherapy with variable modalities. Immunotherapy or targeted therapy was given in cases extensive tumors without the possibility of a surgical treatment or in two patient as an adjuvant treatment after R0 surgery. The three-year overall survival was 50%, and three patients (37.5%) are in remission. HNMM is associated with poor oncologic outcomes regarding the concerned patients of our review, as reported in the literature. New treatments such as immunotherapies or targeted therapies have not significantly changed the prognosis, but they may offer new interesting perspectives. Our small series of cases seems to confirm that surgical resection with negative margins improves overall survival.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>33585548</pmid><doi>10.3389/fsurg.2020.616174</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-875X
ispartof Frontiers in surgery, 2021-01, Vol.7, p.616174-616174
issn 2296-875X
2296-875X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8bfeac46a67040f6a2251dfaea45fe29
source Open Access: PubMed Central
subjects adjuvant radiation therapy
endoscopic surgical procedure
head and neck neoplasm
immunotherapy
late diagnosis
melanoma
Surgery
title Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current Opinion
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A12%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mucosal%20Melanoma%20of%20the%20Head%20and%20Neck:%20A%20Retrospective%20Review%20and%20Current%20Opinion&rft.jtitle=Frontiers%20in%20surgery&rft.au=Pincet,%20Laurence&rft.date=2021-01-20&rft.volume=7&rft.spage=616174&rft.epage=616174&rft.pages=616174-616174&rft.issn=2296-875X&rft.eissn=2296-875X&rft_id=info:doi/10.3389/fsurg.2020.616174&rft_dat=%3Cproquest_doaj_%3E2489598480%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c465t-f71e96bf4af74f0ea3cc4f2c096f703f38cb9d820803465c280e9d5f538f210b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2489598480&rft_id=info:pmid/33585548&rfr_iscdi=true